Quantbot Technologies LP Bicycle Therapeutics PLC Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $1,329 - $2,220	100 Added 33.33%	400 $7,000
Q3 2023 Nov 07, 2023	BUY	$19.9 - $26.25 $5,970 - $7,875	300 New	300 $6,000
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $6,006 - $9,411	300 New	300 $6,000
Q2 2022 Aug 09, 2022	BUY	$12.95 - $46.99 $46,775 - $169,727	3,612 New	3,612 $60,000
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $22,427 - $33,260	-559 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$41.7 - $61.14 $23,310 - $34,177	559 New	559 $34,000

111

40.7M

3.4K

12.4K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $674M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.